Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by carduon Dec 15, 2008 6:44pm

308 Views

Post# 15647420

RE: RE: RE: why doesn't ONC SP respond like this?

I'm not into conspiracy theories,but, I'm at a lost to explain the dismal level of the SP. Considering all the "good" news in the last little while, this stock SHOULD be trading much higher than it is. At least $7-10 IMO.

A few years ago it was at around $20/share, and that was WAY before the current results of efficacy.

Bullboard Posts

Bragg’s iGaming platform drops in Brazil